Incyte Corporation

OVERVIEW

Incyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.

Since 2002 Incyte has remained committed to the relentless pursuit of science that can improve the lives of patients, make a difference in healthcare and build sustainable value for our stakeholders.

Incyte’s unique expertise in medicinal chemistry and biology have enabled us to create a diversified pipeline of clinical candidates, the majority of which were discovered by Incyte scientists. We are advancing a growing portfolio of medicines across Oncology and Inflammation & Autoimmunity.

Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For more information, visit Incyte.com and follow @Incyte.

Learn more about Incyte Corporation

INCYTECARES OVERVIEW

IncyteCARES helps eligible patients access Incyte products through several patient assistance options

• Reimbursement support including benefit verification or prior authorization follow ups and appeal information
• Savings program for patients with commercial prescription insurance*
• Financial Assistance Options*
• Delivery Coordination
• Temporary Supply for Coverage Delays
• Education and Ongoing Support

* Terms and conditions apply. Terms of these programs may change at any time.

IncyteCARES program representatives provide patients with continuing education and personalized support about their condition.  Visit IncyteCARES.com

A LIBRARY OF MPN RESOURCES

MPN Connect is a website designed for healthcare providers that offers a variety of professional resources about myeloproliferative neoplasms (MPNs)—including myelofibrosis, polycythemia vera, and essential thrombocythemia. These include informative articles, diagnostic tools, videos and podcasts from industry leaders, and more.